SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001785530-23-000034
Filing Date
2023-11-14
Accepted
2023-11-14 16:34:46
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K howl-20231114.htm   iXBRL 8-K 27112
2 EX-99.1 a09302023ex991.htm EX-99.1 66241
6 werewolflogohorizontalaa.jpg GRAPHIC 277881
  Complete submission text file 0001785530-23-000034.txt   616954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20231114.xsd EX-101.SCH 1948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20231114_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20231114_pre.xml EX-101.PRE 13623
8 EXTRACTED XBRL INSTANCE DOCUMENT howl-20231114_htm.xml XML 2919
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40366 | Film No.: 231407161
SIC: 2834 Pharmaceutical Preparations